Page 6 - Nasdaq Mrns News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq mrns. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Mrns Today - Breaking & Trending Today

Marinus Pharmaceuticals (NASDAQ:MRNS) Shares Down 4.1%

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) shares fell 4.1% on Tuesday . The company traded as low as $10.16 and last traded at $10.18. 231,219 shares were traded during mid-day trading, a decline of 66% from the average session volume of 675,620 shares. The stock had previously closed at $10.61. Wall Street Analysts […] ....

News Ratings For Marinus Pharmaceuticals Daily , Hedge Funds Weigh In On Marinus Pharmaceuticals , Marinus Pharmaceuticals , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals Company Profile , Denali Advisors , Marinus Pharmaceuticals Stock Performance , Get Free Report , Truist Financial , Street Group , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Trading 1.7% Higher

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report)’s stock price traded up 1.7% during mid-day trading on Thursday . The stock traded as high as $10.35 and last traded at $10.31. 437,213 shares changed hands during trading, a decline of 35% from the average session volume of 677,126 shares. The stock had previously closed at $10.14. […] ....

News Ratings For Marinus Pharmaceuticals Daily , Marinus Pharmaceuticals , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals Stock Performance , Denali Advisors , Royal Bank , Cantor Fitzgerald , Institutional Trading Of Marinus Pharmaceuticals , Free Report , Truist Financial , Street Group , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Shares Down 4.1%

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report)’s share price dropped 4.1% during trading on Thursday . The stock traded as low as $10.52 and last traded at $10.52. Approximately 381,803 shares traded hands during mid-day trading, a decline of 43% from the average daily volume of 666,755 shares. The stock had previously closed at $10.97. […] ....

Cantor Fitzgerald , Capital Management , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals , Institutional Investors Weigh In On Marinus Pharmaceuticals , Mirabella Financial Services , Marinus Pharmaceuticals Price Performance , Opaleye Management Inc , News Ratings For Marinus Pharmaceuticals Daily , Free Report , Truist Financial , Montreal Can , Financial Services , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Hits New 52-Week High at $10.06

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Rating) shares hit a new 52-week high on Friday . The stock traded as high as $10.06 and last traded at $10.06, with a volume of 635541 shares. The stock had previously closed at $9.13. Analysts Set New Price Targets A number of research firms have recently issued reports […] ....

Royal Bank , News Ratings For Marinus Pharmaceuticals Daily , Cantor Fitzgerald , Marinus Pharmaceuticals Stock Performance , Marinus Pharmaceuticals , Geode Capital Management , Hedge Funds Weigh In On Marinus Pharmaceuticals , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals Company Profile , Get Rating , Street Group , Street Corp , Capital Management , Altium Capital Management , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,

Antara Capital LP Raises Stock Position in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)

Antara Capital LP grew its holdings in shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Rating) by 70.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,698,794 shares of the biopharmaceutical company’s stock after purchasing an additional 702,000 shares during the […] ....

Nova Scotia , Quarter For Marinus Pharmaceuticals , News Ratings For Marinus Pharmaceuticals Daily , Geode Capital Management , Marinus Pharmaceuticals Profile , Exchange Commission , Marinus Pharmaceuticals Inc , Vanguard Group Inc , Blackrock Inc , Marinus Pharmaceuticals , Marinus Pharmaceuticals Trading , Cantor Fitzgerald , Opaleye Management Inc , Antara Capital , Get Rating , Montreal Can , Capital Management , Marinus Pharmaceuticals Daily , Nasdaq Mrns , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,